Pandemic controversies: The global response to pandemic influenza must change

January 28, 2013

'Evil' scientists, deadly viruses and terrorist plots are usually the preserve of Hollywood blockbusters. But when it comes to pandemic influenza, it is the stuff of real life. As controversy about research into the H5N1 bird flu virus continues, a new paper argues for a complete overhaul of current approaches to pandemic preparedness.

To Pandemic or Not? Reconfiguring Global Responses to Influenza, by Dr Paul Forster, of the ESRC STEPS Centre, investigates the H1N1 of 2009-10 and sets out some vital lessons if we are to prepare for pandemic influenza effectively, while avoiding confusing and costly mistakes.

When the H1N1 outbreak in 2009-10 was milder than the had predicted, WHO was accused of colluding with the pharmaceutical industry and national governments of squandering billions. The Council of Europe said US$18 billion was wasted, and branded WHO's actions "one of the greatest medical scandals of the century". The event revealed weaknesses in the world's current configuration of planning for and responding to pandemic influenza, according to Dr Forster.

Science, public health policy makers and the worldwide public were confounded by the uncertainty, complexity and politics of and the high emotions it inspires. Amid this confusion, the global and national institutions responsible for protecting public health were shown to be over-reliant on a reductive, science-led approach that prioritised a one-size-fits-all response, and failed to address the needs and priorities of the world's poorest and most vulnerable people. Dr Forster suggests new ways to construct plural responses more suited to tackling the globalised mix of politics, people and pathogens that pandemics produce.

"Preparing for an means preparing for surprises and being ready to respond rapidly and flexibly under conditions of uncertainty. If people across the globe are to be ready, plural and diverse response pathways are required," said Dr Forster, an independent development consultant and STEPS Centre researcher. "The world would be better protected by a re-ordering of and response efforts around the needs of the world's poorest, most vulnerable, and most exposed people," he added.

A re-ordered response would allow the undue pre-eminence of pharmaceuticals to be examined, and bring focus on the pressing need for disease surveillance in animals, scrutiny of contemporary agricultural practices and a broadening of research efforts. It might also refresh the World Health Organization's approach, which Dr Forster believes supports an inflexible and narrow set of interests by default, rather than conspiracy.

With most flu experts agreeing that it is not so much a question of if, but rather when, a new pandemic will arrive, the sooner the lessons of outbreaks such as that in 2009-10 can be learned, the better.

Explore further: At least one in five were infected in flu pandemic, international study suggests

More information: Paper To Pandemic or Not? Reconfiguring Global Responses to Influenza, by Paul Forster: steps-centre.org/publication/pandemics-wp/

Briefing Swine Flu: What went Wrong? A short briefing based on the Working Paper by Paul Forster: steps-centre.org/publication/swine-flu-what-went-wrong/?referralDomain=briefing

Related Stories

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.